Detection of miR-155 Using Peptide Nucleic Acid at Physiological-like Conditions by Surface Plasmon Resonance and

Francesco Lavecchia di Tocco1, Valentina Botti1, Salvatore Cannistraro1

  • 1Biophysics and Nanoscience Centre, DEB, Università della Tuscia, Largo dell'Università, 01100 Viterbo, Italy.

Biosensors
|February 23, 2024
PubMed

Insights

This study presents a novel method for detecting microRNAs (miRNAs) using peptide nucleic acid (PNA) probes and field-effect-transistor biosensors (bioFETs). This approach enables sensitive, real-time, and label-free detection of specific miRNAs like miR-155.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Biosensor Technology

Background:

  • MicroRNAs (miRNAs) are crucial gene regulators implicated in various diseases, including cancer.
  • Altered miRNA expression necessitates sensitive clinical detection methods for biomarker applications.
  • Field-effect-transistor-based biosensors (bioFETs) offer a promising platform for label-free miRNA quantification.

Purpose of the Study:

  • To investigate the detection of human microRNA 155 (miR-155) using a novel peptide nucleic acid (PNA) probe.
  • To optimize a bioFET setup for sensitive and specific miRNA detection.
  • To evaluate the potential of PNA-bioFET systems for clinical applications.

Main Methods:

  • Utilized a synthetic peptide nucleic acid (PNA) as a capturing probe for miR-155 detection.
  • Employed Surface Plasmon Resonance (SPR) to study the interaction kinetics between miR-155 and the PNA probe.
  • Developed and utilized a custom-made bioFET system for real-time, label-free miRNA detection.

Main Results:

  • Demonstrated that PNA probes can form stable duplexes with target miRNAs under physiological conditions.
  • Achieved sensitive detection of miR-155 in the nano-molar range using the PNA-bioFET system.
  • Confirmed high specificity of the PNA-bioFET system for miR-155 detection.

Conclusions:

  • The PNA-bioFET system provides a low-cost, real-time, and highly specific method for miR-155 detection.
  • This technology holds significant potential for developing clinical diagnostic tools for miRNA-related diseases.
  • Further optimization could lead to widespread adoption in clinical settings for miRNA biomarker analysis.

Related Concept Videos